DEA plans to make N-phenethyl-4-piperidone (NPP) a List I chemical in an effort to control the illicit manufacture of fentanyl, a schedule II controlled substance.
Modern Medicine News
Data from a new report reveals that competition from authorized generics during the 180-day exclusivity period leads to lower prices and does not reduce or slow the introduction of new generic pharmaceuticals.
The next 25 years hold promise of more clinical involvement and collaboration ? and more respect for pharmacists.
Pay dirt: Pharmacist salaries are still climbing, but at a slower rate. Our exclusive survey shows who gets top dollar
Pharmacist salaries are still climbing, but at a slower rate. Our exclusive survey shows who gets top dollar.
Just a few years ago switching to a generic drug without consulting a physician or discussing it with the patient was a rare thing for a pharmacist to do. But the times are a-changin'.